November 7, 2013
SASKATOON – November 7, 2013 – Genome Prairie announced today the appointment of Dr. Lisette Mascarenhas as Director of Business Development – Saskatoon Office. In this role, Dr. Mascarenhas will identify and enable the development of industry relevant bioscience projects with strong social and economic benefits.
During her more than 22 years within the bioscience community, Dr. Mascarenhas has demonstrated experience in the translation of research discoveries into tangible products and services. Lisette completed a PhD in 1999 and a Masters of Business Administration in 2004 at the University of Saskatchewan. Following the completion of her MBA, she managed a multidisciplinary, multi-million dollar Genome Canada project focused on the development and clinical implementation of diagnostic tools for organ transplant patients. In 2006 she joined AgWest Bio Inc. as Vice President of Investments and Health, where her primary goal was to manage its investment portfolio and assist early-stage life science companies in generating profit. In 2009, she joined Springboard West Innovations Inc. as a Senior Innovation Officer, where she applied her significant expertise to enable life science companies to turn technology ideas into commercial realities through mentorship, pathfinding, prototype development, attracting investments, and growth management.
“We are extremely pleased to announce the appointment of Dr. Mascarenhas,” said Dr. Reno Pontarollo, President and Chief Executive Officer, Genome Prairie. “Her track record of excellence in research, development and commercialization proves that she is able to ‘bridge the gap’ between research and industry. In this role, she will work closely with our Director of Business Development in Manitoba to bring maximum benefits to the prairie provinces.”
Genome Prairie, a non-profit-organization, aligns partners and resources to develop and manage research projects addressing key regional priorities such as agriculture, human health, the environment, energy and mining. These efforts are playing a central role in building the region’s reputation as a location of choice for innovation and commercialization. For more information, visit www.genomeprairie.ca
###
For additional information, contact:
Kari Doerksen, Acting Director of Communications
Genome Prairie
Tel: (306) 668-3570
kdoerksen@genomeprairie.ca
